Clark Estates Inc Gilead Sciences, Inc. Transaction History

Clark Estates Inc

$430 Million
Q1 2024

A detailed history of Clark Estates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clark Estates Inc holds 44,975 shares of GILD stock, worth $3 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

44,975

Previous 57,475 21.75%

Holding current value

$3 Million

Previous $4.66 Million 29.25%

% of portfolio

0.77%

Previous 1.07%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $894,750 - $1.09 Million	-12,500 Reduced 21.75%	44,975 $3.29 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $844,611 - $962,274	-10,925 Reduced 15.97%	57,475 $4.77 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $4.05 Million - $4.62 Million	-68,000 Reduced 49.85%	68,400 $4.22 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $924,000 - $1.05 Million	15,400 Added 12.73%	136,400 $8.82 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $3.85 Million - $4.39 Million	68,000 Added 128.3%	121,000 $7.05 Million

Q4 2019 Feb 05, 2020	BUY	$61.62 - $67.78 $394,368 - $433,792	6,400 Added 13.73%	53,000 $3.44 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $2.91 Million - $3.22 Million	46,600 New	46,600 $2.95 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $3.07 Million - $3.44 Million	-49,550 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $106,920 - $118,380	1,500 Added 3.12%	49,550 $3.83 Million
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $3.46 Million - $4.11 Million	48,050	48,050 $3.89 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark Estates Inc with notifications on news.

Account

Clark Estates Inc Gilead Sciences, Inc. Transaction History